Search

everythinglearnresearchcommunity

for

Search:↓

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

A specific thyroid hormone resistance mutation may be linked to different types of hair loss.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Amniotic allograft may be more effective than platelet-rich plasma for midface aging treatment.

Certain genes are linked to the risk of developing Alopecia Areata.

Terbinafine can cause hair loss.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.